An Overview of ICA/BSS-Based Application to Alzheimer's Brain Signal Processing

Biomedicines. 2021 Apr 6;9(4):386. doi: 10.3390/biomedicines9040386.

Abstract

Alzheimer's disease (AD) is by far the most common cause of dementia associated with aging. Early and accurate diagnosis of AD and ability to track progression of the disease is increasingly important as potential disease-modifying therapies move through clinical trials. With the advent of biomedical techniques, such as computerized tomography (CT), electroencephalography (EEG), magnetoencephalography (MEG), positron emission tomography (PET), magnetic resonance imaging (MRI), and functional magnetic resonance imaging (fMRI), large amounts of data from Alzheimer's patients have been acquired and processed from which AD-related information or "signals" can be assessed for AD diagnosis. It remains unknown how best to mine complex information from these brain signals to aid in early diagnosis of AD. An increasingly popular technique for processing brain signals is independent component analysis or blind source separation (ICA/BSS) that separates blindly observed signals into original signals that are as independent as possible. This overview focuses on ICA/BSS-based applications to AD brain signal processing.

Keywords: Alzheimer’s disease; MRI; blind signal separation; brain signal processing; fMRI; independent component analysis.

Publication types

  • Review